Physician profile
Carl A Smart
NPI 1518986652
$33,954.00
in general payments reported to CMS, 2019-2025
38 companies · $2,248 in 2025
The $2,248 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $7,404 · 2021: $12K · 2022: $7,984 · 2023: $2,336 · 2024: $1,512 · 2025: $2,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,983 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,983.40 |
| Education | $113.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $27,563.00 | 2020-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,634.44 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Amgen INC. | $848.07 | 2021-2025 | Tezspire |
| Genzyme Corporation | $803.08 | 2023-2025 | |
| Mylan Specialty L.P. | $354.88 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $312.41 | 2021-2025 | Dupixent |
| Philips North America LLC | $301.74 | 2019-2025 | Vest Therapy Und |
| Insmed, INC. | $194.53 | 2019-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $174.48 | 2023-2024 | Acthar |
| Baxter Healthcare | $168.62 | 2022-2023 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $157.23 | 2020-2025 | Prolastin-C Liquid, Xembify |
| Ani Pharmaceuticals, INC. | $150.98 | 2023-2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $118.81 | 2023-2024 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $115.82 | 2023-2025 | Glassia, Cuvitru |
| Inspire Medical Systems, INC. | $113.31 | 2024-2025 | Inspire |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $111.99 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.32 | 2021-2025 | Spiriva Respimat, Stiolto Respimat, Jascayd |
| Novartis Pharmaceuticals Corporation | $85.49 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $79.00 | 2022-2024 | Nuzyra |
| Genentech USA, INC. | $66.63 | 2022-2023 | Xolair |
| E.R. Squibb & Sons, L.L.C. | $56.34 | 2021-2023 | |
| Advanced Respiratory, INC | $45.13 | 2021 | |
| Pulmonx Corporation | $40.49 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Lilly USA, LLC | $39.48 | 2025 | Zepbound |
| Phadia US INC. | $39.31 | 2022 | |
| Aytu Biopharma, INC. | $35.77 | 2023 | Karbinal |
| Electromed, INC. | $30.42 | 2024-2025 | Smartvest |
| Verona Pharma, INC. | $27.47 | 2025 | Ohtuvayre |
| Csl Behring | $24.37 | 2020 | |
| Viatris Specialty LLC | $23.16 | 2025 | Yupelri |
| Vifor Pharma, INC. | $22.18 | 2025 | Zemaira |
| Hikma Pharmaceuticals USA | $19.78 | 2024 | Ryaltris |
| Bayer Healthcare Pharmaceuticals INC. | $18.86 | 2023 | |
| Nabriva Therapeutics, Plc | $16.62 | 2022 | |
| Circassia INC. | $15.88 | 2019 | |
| Tactile Systems Technology INC | $13.52 | 2025 | Flexitouch Plus, Nimbl |
| Resmed Corp | $13.32 | 2023 | |
| Mylan Pharmaceuticals INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Smart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.